a PK (Kaletra 133.3 mg / 33.3 mg)
Generic Name: lopinavir/ritonavir
Pill with imprint a PK is Orange, Capsule-shape and has been identified as Kaletra 133.3 mg / 33.3 mg. It is supplied by Abbott Laboratories.
Kaletra is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Kaletra 133.3 mg / 33.3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for a PK
Kaletra
- Generic Name
- lopinavir/ritonavir
- Imprint
- a PK
- Strength
- 133.3 mg / 33.3 mg
- Color
- Orange
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Abbott Laboratories
- National Drug Code (NDC)
- 00074-3959
More about Kaletra (lopinavir / ritonavir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Generic Availability
- Drug class: protease inhibitors
- FDA Alerts (4)
Consumer resources
- Kaletra
- Kaletra (Advanced Reading)
- Kaletra (Lopinavir and Ritonavir Oral Solution)
- Kaletra (Lopinavir and Ritonavir Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
